Alibaba
BABA
NVIDIA
NVDA
Cisco
CSCO
Netflix
NFLX
Apple
AAPL
US Stock MarketDetailed Quotes
ACET Adicet Bio
- 0.992
- +0.092+10.27%
Close Feb 14 16:00 ET
- 0.956
- -0.036-3.63%
Post 19:57 ET
81.73MMarket Cap-0.58P/E (TTM)
1.010High0.902Low596.60KVolume0.910Open0.900Pre Close574.95KTurnover0.98%Turnover RatioLossP/E (Static)82.40MShares2.61052wk High0.39P/B60.59MFloat Cap0.81052wk Low--Dividend TTM61.08MShs Float214.348Historical High--Div YieldTTM12.00%Amplitude0.810Historical Low0.963Avg Price1Lot Size
Adicet Bio Stock Forum
Sign in to post a comment
$Adicet Bio (ACET.US)$ is this going to pump?
1
$Adicet Bio (ACET.US)$ Thinking of buying some shares at these levels just for exposure with a SLO below 0.85. Very unusual trading volume today imo.
$Adicet Bio (ACET.US)$ add layer guys, we going to take off,
1
1
2
4
$Adicet Bio (ACET.US)$
I'm in
I'm in
1
1
$Adicet Bio (ACET.US)$
Revolutionary Lupus Treatment Gets FDA Fast-Track: Adicet's ADI-001 Could Transform Patient Care
Revolutionary Lupus Treatment Gets FDA Fast-Track: Adicet's ADI-001 Could Transform Patient Care
1
$Adicet Bio (ACET.US)$ Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement
1 MINUTE AGO, 7:10 AM EST
VIA BUSINESSWIRE
1 MINUTE AGO, 7:10 AM EST
VIA BUSINESSWIRE
1
$Adicet Bio (ACET.US)$
Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement
Wednesday, 5th February at 7:10 am
Adicet Bio, Inc. (NASDAQ: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-001 for ...
Adicet Bio Receives FDA Fast Track Designation for ADI-001 for the Treatment of Refractory Systemic Lupus Erythematosus (SLE) with Extrarenal Involvement
Wednesday, 5th February at 7:10 am
Adicet Bio, Inc. (NASDAQ: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to ADI-001 for ...
1
No comment yet
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Bear trap : and down